AngioDynamics Fights For New Trial In CR Bard Patent Case
AngioDynamics says it should get a new trial after a Delaware federal jury found the company's implantable port products infringed medical device maker C.R. Bard's patents, claiming that "Bard's trial presentation...To view the full article, register now.
Already a subscriber? Click here to view full article